Dongguang Wang

Dongguang Wang

Auto-generated profile, based on publicly available information

Dongguang Wang

Department of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2019 in Solar Physics
Verified
Journal Article
Closed access
PDF file
GZGaofei Zhu
Gaofei Zhu
GLGanghua Lin
Ganghua Lin
DWDongguang Wang
Dongguang Wang
SLSuo Liu
Suo Liu
XYXiao Yang
Xiao Yang

1 November 2021 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
DWDongguang Wang
Dongguang Wang
LCLingmin Chen
Lingmin Chen
LWLian Wang
Lian Wang
Fang HuaFang Hua
Fang Hua
JLJuan Li
Juan Li
MCMike Clarke
Mike Clarke
To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Linear regression analyses were used to identify potential predictors. Forty RCT abstracts were included in our assessment of reporting quality, and a higher word count in the abstract was significantly correlated with higher reporting scores (95% CI 0.044 to 0.658, P=0.026). Multiple spin strategies were identified. Our multivariate analyses showed that geographical origin was associated with severity of spin, with research from non-Asian regions containing fewer spin strategies (95% CI -0.760 to -0.099, P=0.013). The reporting quality of abstracts of RCTs of interventions for COVID-19 is far from satisfactory. A relatively high proportion of the abstracts contained spin, and the findings reported in the results and conclusion sections of these abstracts need to be interpreted with caution.

5 November 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
XTXiang Tong
Xiang Tong
SZShijie Zhang
Shijie Zhang
DWDongguang Wang
Dongguang Wang
LZLi Zhang
Li Zhang
JHJizheng Huang
Jizheng Huang
HFHong Fan
Hong Fan
Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a mouse PF model induced by bleomycin (BLM) and primary mouse lung fibroblasts stimulated by transforming growth factor (TGF)-β1 to explore the possible mechanisms of AZM in PF. Results showed that AZM reduces mortality and lung inflammation and attenuates BLM-induced PF in mice. AZM effectively reduced the expression of α-smooth muscle actin (SMA) and type I collagen. Meanwhile, expression of lysyl oxidase (LOX) and lysyl oxidase-like protein (LOXL)-2 in the lung tissue of mice after AZM treatment was significantly lower than in the BLM group. In addition, this study found that AZM significantly inhibits the TGF-β1/Smad and JNK/c-Jun signaling pathways in vivo, and expression of a-SMA, type I collagen, LOX and LOXL-2 in the lung tissue of mice treated with AZM was significantly lower than that in the BLM group. In vitro, AZM also effectively inhibited type I collagen, LOX, LOXL-2 and JNK-c-Jun signaling pathways in TGF-β1-stimulated primary mouse fibroblasts, and this effect was similar to that of a JNK-specific inhibitor (SP600125). In conclusion, AZM effectively attenuated BLM-induced PF in mice, which may play a role by partially inhibiting the JNK/c-Jun and TGF-β1/Smad signaling pathways and reducing production of LOX and LOXL2.

17 January 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
SZShi-Jie Zhang
Shi-Jie Zhang
XTXiang Tong
Xiang Tong
TZTianli Zhang
Tianli Zhang
DWDongguang Wang
Dongguang Wang
SLSitong Liu
Sitong Liu
HFHong Fan
Hong Fan
Background: Sarcoidosis-associated pulmonary hypertension (SAPH) is associated with poor prognosis, conferring up to a 10-fold increase in mortality in patients with sarcoidosis, but the actual prevalence of SAPH is unknown.Methods: The PubMed, Embase, and Cochrane Library databases were systematically searched for epidemiological studies reporting the prevalence of SAPH up to July 2021. Two reviewers independently performed the study selection, data extraction, and quality assessment. Studies were pooled using random-effects meta-analysis.Results: This meta-analysis included 25 high-quality studies from 12 countries, with a pooled sample of 632,368 patients with sarcoidosis. The prevalence of SAPH by transthoracic echocardiography in Europe, the United States and Asia was 18.8% [95% confidence interval (CI): 11.1–26.5%], 13.9% (95% CI: 5.4–22.4%) and 16.2% (95% CI: 7.1–25.4%) separately, and the overall pooled prevalence was 16.4% (95%CI: 12.2–20.5%). By right heart catheterization (RHC), the pooled prevalence of SAPH was 6.4% (95% CI: 3.6–9.1%) in general sarcoidosis population, and subgroup analyses showed that the prevalence of SAPH was 6.7% (95% CI: 2.4–11.0%) in Europe and 8.6% (95% CI: −4.1 to 21.3%) in the United States. Further, the prevalence of pre-capillary PH was 6.5% (95% CI: 2.9–10.2%). For the population with advanced sarcoidosis, the pooled prevalence of SAPH and pre-capillary PH by RHC was as high as 62.3% (95% CI: 46.9–77.6%) and 55.9% (95% CI: 20.1–91.7%), respectively. Finally, the pooled prevalence of SAPH in large databases with documented diagnoses (6.1%, 95% CI: 2.6–9.5%) was similar to that of RHC. Substantial heterogeneity across studies was observed for all analyses (I2 > 80%, P < 0.001).Conclusions: The sarcoidosis population has a relatively low burden of PH, mainly pre-capillary PH. However, as the disease progresses to advanced sarcoidosis, the prevalence of SAPH increases significantly.

1 October 2020 in The Astrophysical Journal
Verified
Journal Article
Closed access
GZGaofei Zhu
Gaofei Zhu
GLGanghua Lin
Ganghua Lin
DWDongguang Wang
Dongguang Wang
XYXiao Yang
Xiao Yang
This paper presents a new approach for the regression of the center coordinates and radius of the solar disk in Hα solar full-disk images by using a Deep Convolutional Neural Network. We use ∼100,000 original Hα solar full-disk images obtained from Huairou Solar Observing Station as the experimental data set. The data set includes two parts: the original image and three numeric values (center coordinates and radius). In order to deal with the uneven distribution of the solar disk position in the original image, we randomly shift the solar disk during image preprocessing. Furthermore, data augmentation is also used to increase the robustness of the model. By evaluating the model with R-square and relative error, the center coordinates and the radius of the solar disk are proved to be effectively regressed. The data sets we constructed and source code are available as open source on GitHub.